Competition Appellate Tribunal quashes penalties finding no anti-competitive agreement under Section 3 due to coercion

The Competition Appellate Tribunal allowed the appeal and set aside the Commission's order. The Tribunal found that the informant deliberately suppressed vital facts and documents from the Commission, though no penalty was imposed. The Commission's findings regarding anti-competitive practices under Section 3 were deemed self-contradictory and perverse, as coercion by one party negated the element of agreement required for violation. The Tribunal held that Section 48(1) could not be invoked against individual appellants without first establishing company contravention and without providing them adequate opportunity to defend. The penalty imposed on all appellants was quashed due to lack of evidence supporting anti-competitive conduct allegations.

---

---

1. ISSUES PRESENTED and CONSIDERED

The core legal issues considered in the judgment include:

• Whether the suppression of facts by the Informant (Respondent No. 2) makes the proceedings infructuous and whether the Informant is liable to be penalized under section 45(1)(b) of the Competition Act, 2002.
• Whether the conduct/practices of Alkem Laboratories Ltd. (Appellant No. 1) and/or All Kerala Chemists and Druggists Association (AKCDA - Respondent No. 3) amount to contravention of any provisions of section 3 of the Competition Act, 2002.
• Whether Appellants Nos. 2 and 3 can be held liable under Section 48(1) of the Act for the anti-competitive conduct of Appellant No. 1.

2. ISSUE-WISE DETAILED ANALYSIS

Issue 1: Suppression of Facts by the Informant

• Relevant Legal Framework and Precedents: Section 45(1)(b) of the Competition Act, 2002, which deals with penalties for making false statements or omissions.
• Court's Interpretation and Reasoning: The Commission found that the Informant had suppressed material facts, such as his appointment as a stockist by Appellant No. 3 and the supply of medicines, which could have influenced the Commission's decision to initiate an investigation.
• Conclusions: Despite the suppression, the Commission did not penalize the Informant, concluding that the non-disclosure was not significant enough to warrant action under Section 45(1)(b).

Issue 2: Anti-competitive Conduct of Appellant No. 1 and AKCDA

• Relevant Legal Framework and Precedents: Section 3(1) of the Competition Act, 2002, which prohibits anti-competitive agreements.
• Court's Interpretation and Reasoning: The Commission found that AKCDA had been issuing diktats to pharmaceutical companies to obtain NOC before appointing stockists, which Appellant No. 1 allegedly complied with, thus contravening Section 3(1).
• Key Evidence and Findings: The Commission relied on complaints and communications suggesting that AKCDA exerted pressure on pharmaceutical companies, including Appellant No. 1, to follow its instructions.
• Conclusions: The Commission concluded that Appellant No. 1 acted in violation of Section 3(1) by facilitating AKCDA's anti-competitive practices.

Issue 3: Liability of Appellants Nos. 2 and 3 under Section 48(1)

• Relevant Legal Framework and Precedents: Section 48(1) of the Competition Act, 2002, which holds individuals in charge of a company liable for the company's contraventions.
• Court's Interpretation and Reasoning: The Commission found Appellants Nos. 2 and 3 liable under Section 48(1) based on their positions within the company, despite a lack of direct evidence showing their involvement in the anti-competitive conduct.
• Conclusions: The Tribunal found that the Commission's decision to hold Appellants Nos. 2 and 3 liable was not supported by evidence and violated principles of natural justice.

3. SIGNIFICANT HOLDINGS

• Core Principles Established: The judgment emphasizes the need for evidence to support findings of contravention under Section 3(1) and the importance of adhering to principles of natural justice, especially when invoking Section 48(1) to hold individuals liable.
• Final Determinations on Each Issue: The Tribunal set aside the Commission's findings against Appellants Nos. 1, 2, and 3, concluding that the evidence did not support the allegations of anti-competitive conduct or the individual liability of Appellants Nos. 2 and 3.

The Tribunal's decision underscores the necessity for thorough and evidence-based investigations in competition law cases and highlights the procedural safeguards that must be observed to ensure fair adjudication.

---